The UNC Eshelman School of Pharmacy is a key member of the robust research arm of the University of North Carolina at Chapel Hill.

Our faculty are leaders and innovators in their areas of research, and the School’s proximity to the Research Triangle Park and other research campuses spurs collaboration and partnerships in academia and with industry. Research at the School has spawned a number of spin-off companies, and in 2009, the School led the University with twenty-six invention disclosures and four patents received.

If you are looking for opportunities for research collaboration, please visit the Global Engagement section of our website, or explore our Eshelman Institute for Innovation’s resources for entrepreneurial development.

A Unique Perspective

The UNC Eshelman School of Pharmacy provides a unique perspective among peer institutions in our approach to research. The School conducts a wide range of advanced research that aligns with five phases of the drug discovery, development and delivery cycle.

Each phase is represented by a division within the School. Faculty and graduate students alike are encouraged to work with their peers within the School and the University to further realize research goals in discovery, preclinical and clinical development of therapeutic agents, optimum delivery of drug therapy, evaluation of health and therapeutic outcomes of novel drug therapies and technologies, as well as regulatory policies.

Recent Research News

Patients Satisfied with Pharmacists Conducting Wellness Visits

February 19, 2018

Patients undergoing a Medicare annual wellness visit say they would be satisfied and comfortable with having a clinical pharmacist practitioner working alone conduct the visit rather than having a physician do it, according to a new study from the University … Continued

Continuing Education for Pharmacists Falls Short on Naloxone

February 16, 2018

Pharmacists who are allowed to dispense naloxone, an opioid reversal agent, without a prescription are often uncomfortable talking to patients about the drug, and the profession’s continuing education programs aren’t helping, according to a new study from the University of … Continued

Bryan Roth

UNC Scientists Take a Big Step toward a Better Opioid

January 10, 2018

For the first time, scientists at the University of North Carolina at Chapel Hill and collaborators solved the crystal structure of the activated kappa opioid receptor bound to a morphine derivative. They then created a new drug-like compound that activates only that … Continued


Read More